Up to 2030, the pharmaceuticalgant will send $ 50 billion in the development of capacities to the United States. The main thing is the new factory in Virginia.
British pharmaceutical company Astrazeneca plans to invest $ 50 billion in expanding its existence in the United States, including the creation of the world’s largest production hub in Virginia. CNBC reported it.
It is noted that by 2030 the pharmaceutical gym will direct $ 50 billion in developing research and production capacities in the United States. The main thing is the new factory in Virginia, where innovative drugs for weight control and metabolic disorders will be performed, including GLP-1 based on oral-based oral oral.
It has been reported that the new facility will be the largest production site of a pharmaceutical company worldwide. This provides for the widespread implementation of artificial intelligence, automation and data analysts to increase production efficiency.
Astrazeneca also plans to measure activities in the field of cell therapy – in the states of Maryland, Massachusetts, California, Indiana and Texas. Within the framework of this approach, thousands of new jobs will be created.
According to the general director of Pascal Sorio, the investment is evidence of faith in the American Biopharmaceutical ecosystem. They should also help the company achieve an ambitious goal – to increase the annual income to $ 80 billion, half of it is planned to receive from the US market.
We reminded, earlier reported that the pharmaceutical company Astrazeneca remembered its vaccine against COVID-19 worldwide due to “extremely accessible improved vaccine” since the beginning of Pandemya.
News from CORRESPONDENT.NET On the telegram and whatsapp. Subscribe to our channels https://t.me/KorresPondentNet and WhatsApp
Source: korrespondent
I’m Liza Grey, an experienced news writer and author at the Buna Times. I specialize in writing about economic issues, with a focus on uncovering stories that have a positive impact on society. With over seven years of experience in the news industry, I am highly knowledgeable about current events and the ways in which they affect our daily lives.